Improving treatment strategies for opioid use disorder
OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23)
This study is all about finding better ways to help people with opioid use disorder stick with their treatment, figure out how long they should stay on medication, and know when it’s the right time to stop taking it, all to support their recovery and health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-11220969 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of pharmacotherapy for individuals struggling with opioid use disorder. It aims to optimize strategies for retaining patients in treatment, determining the appropriate duration of therapy, and identifying the best times to discontinue medication. By employing a comprehensive approach, the research seeks to address the challenges faced by patients in managing their addiction and improving their overall health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are currently receiving or are eligible for pharmacotherapy.
Not a fit: Patients who are not struggling with opioid use disorder or those who are not seeking treatment for their addiction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment protocols for opioid use disorder, ultimately helping patients achieve better recovery outcomes.
How similar studies have performed: Previous research has shown promising results in optimizing treatment strategies for opioid use disorder, indicating that this approach has the potential for success.
Where this research is happening
Rockville, United States
- The Emmes Company, LLC — Rockville, United States (Active)
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.